Poseida Therapeutics Insider Trades

PSTX

Track insider trading activity from Poseida Therapeutics executives and directors. See which insiders are buying and selling PSTX stock.

Trades Last 12 Months

All Insider Trades for Poseida Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Yarema Kristin President And CEO
Holding Value $0 0 shares
Last Trade
Jan 08, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$5.54M 615,836 shares
$9.00
$9.50
Baum Charles M Director
Holding Value $0 0 shares
Last Trade
Jan 08, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$260k 27,350 shares
$9.50
$9.50
Collins Cynthia Director
Holding Value $0 0 shares
Last Trade
Jan 08, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.62M 170,640 shares
$9.50
$9.50
Corning Luke Director
Holding Value $0 0 shares
Last Trade
Jan 08, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$966k 101,683 shares
$9.50
$9.50
Gergen Mark J President And CEO
Holding Value $0 0 shares
Last Trade
Jan 08, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$5.73M 636,726 shares
$9.00
$9.50
Leonhardt Harry J GC & Chief Compliance Officer
Holding Value $0 0 shares
Last Trade
Jan 08, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.25M 137,000 shares
$9.15
$9.50
Holding Value $0 0 shares
Last Trade
Jan 08, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$621k 68,950 shares
$9.00
$9.50
Holding Value $0 0 shares
Last Trade
Jan 08, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$112M 11,835,673 shares
$9.50
$9.50
Mylet Johanna Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Jan 08, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$2.29M 254,852 shares
$9.00
$9.50
Rizvi Syed Ali Aamir Chief Medical Officer
Holding Value $0 0 shares
Last Trade
Jan 08, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.38M 250,000 shares
$9.50
$9.50
Schmid John P. Director
Holding Value $0 0 shares
Last Trade
Jan 08, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$531k 58,950 shares
$9.00
$9.50
Amado Rafael Director
Holding Value $0 0 shares
Last Trade
Jan 08, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$784k 82,550 shares
$9.50
$9.50
Warner Brent President, Gene Therapy
Holding Value $4.32M 454,779 shares
Last Trade
Mar 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$461k 111,700 shares
$4.13
$9.50
Ostertag Eric Director
Holding Value $7.86M 827,320 shares
Last Trade
Feb 01, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$82.4k 11,776 shares
$7.00
$9.50
Ingalls Kerry D. Chief Operating Officer
Holding Value $523k 55,000 shares
Last Trade
Mar 16, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$11.9k 3,000 shares
$3.98
$9.50
Spear Matthew A. Chief Medical Officer
Holding Value $1.06M 111,485 shares
Last Trade
Mar 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$248k 72,568 shares
$3.42
$9.50
Hirsch David Director
Holding Value $245k 25,833 shares
Last Trade
Jul 23, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$223k 25,833 shares
$8.63
$9.50
Novartis Pharma Ag 10% owner
Holding Value $0 0 shares
Last Trade
Jul 14, 2020 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$95.8M 7,367,387 shares
$13.01
$9.50
Holding Value $190k 20,000 shares
Last Trade
Jul 09, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$9.50
Francis, John P. Director
Holding Value $0 0 shares
Last Trade
Mar 24, 2014 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
No data
No data
$9.50

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up